The Yale Center for the Science of Cannabis and Cannabinoids (YC-SCAN²) is awarding over $600,000 in grants to 14 Yale School of Medicine researchers to conduct cannabis research. Specifically, the grants will fund investigations into the impact of cannabis and cannabinoids on neurodevelopment and mental health.
YC-SCAN², established in 2023, is managed and directed by Deepak Cyril D’Souza, MD, Vikram Sodhi ’92 Professor of Psychiatry. The department was designed to be a research hub for medicinal cannabis research, and the findings “will be disseminated and used to educate the scientific community, healthcare professionals, and the public,” according to a press release.
“We received a highly competitive set of applications making for a challenging selection process. We are grateful to our reviewers who brought their expertise in basic and clinical sciences in reviewing these applications,” Dr. S’Souza said.
“The projects cover a broad range of topics from the effects of cannabinoids on fetal neurodevelopment and adolescent brain development, the therapeutic potential of beta-caryophyllene for pain, to the impact of cannabis in schizophrenia. The projects are led by investigators at different stages of their careers utilizing several novel approaches. We are optimistic that these projects will advance the science of cannabis and